Author:
Xue Siqi,Qin Zhiying,Ren Guanghui,Yang Zhongjie,Lu Yang,Zhang Yongjie,Li Ning,Chen Xijing,Zhao Di
Funder
Fundamental Research Funds for the Central Universities
“Double First-Class” initiative Innovation team project of China Pharmaceutical University
Natural Science Foundation of China
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference24 articles.
1. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity;Hikida;Antimicrob. Agents Chemother.,1999
2. In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections;Miyazaki;Antimicrob. Agents Chemother.,2001
3. Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084;Isoda;J. Antibiot.,2006
4. Population pharmacokinetics of tebipenem pivoxil (ME1211), a novel oral carbapenem antibiotic, in pediatric patients with otolaryngological infection or pneumonia;Sato;Drug Metab. Pharmacokinet.,2008
5. Pharmacokinetics of tebipenem pivoxil, a novel oral carbapenem antibiotic, in experimental animals;Kijima;Jpn. J. Antibiot.,2009
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献